What is Diffuse Alveolar Hemorrhage (DAH)?
Diffuse alveolar hemorrhage (DAH) is a life-threatening clinical syndrome characterized by bleeding from the pulmonary microcirculation into the alveolar spaces, resulting in acute respiratory failure, anemia, and diffuse radiological infiltrates. 1
Clinical Presentation
The classic triad consists of:
- Acute respiratory failure with dyspnea
- Anemia with falling hemoglobin
- Diffuse pulmonary infiltrates on imaging
Critical caveat: Hemoptysis is absent in up to 50% of cases, making diagnosis challenging and requiring high clinical suspicion 2, 1. When present, hemoptysis occurs in approximately two-thirds of patients 2.
Underlying Pathophysiology
DAH results from injury to the alveolar-capillary microcirculation, manifesting in three distinct histopathological patterns 1:
- Pulmonary capillaritis - Associated with immune-mediated vasculitis (ANCA-associated vasculitis, anti-GBM disease)
- Bland alveolar hemorrhage - Reflects coagulopathy or hemodynamic factors
- Diffuse alveolar damage - Linked to toxins, infections, or ARDS
Pathologically, DAH shows intra-alveolar hemorrhage, hemosiderin-laden macrophages in alveolar spaces and interstitium, and occasional focal or diffuse areas of capillaritis 2.
Etiologies
Immunologic Causes (Most Common)
- ANCA-associated vasculitis (microscopic polyangiitis, granulomatosis with polyangiitis)
- Anti-glomerular basement membrane disease
- Systemic lupus erythematosus (rare but devastating complication) 3
- Other connective tissue diseases
Non-Immunologic Causes
- Coagulopathies and anticoagulation
- Drug-induced (cocaine, opioids, chemotherapy agents) 4, 5
- Infections
- Hemodynamic disturbances
- Hematologic malignancies (rare initial presentation) 4
Diagnostic Approach
Diagnosis requires three key elements:
Imaging findings: Bilateral patchy ground-glass opacities or consolidation in middle and lower lung zones on chest radiograph; diffuse or geographic ground-glass opacities/consolidation on CT 2
Bronchoalveolar lavage (BAL): Progressively bloodier returns on sequential aliquots and hemosiderin-laden macrophages 1
Laboratory evaluation:
- Complete blood count showing anemia
- ANCA, anti-GBM antibodies
- Coagulation studies
- Infectious workup to exclude mimics
The most critical differential diagnosis is infection, which must be meticulously excluded before initiating immunosuppression 2.
Clinical Context in Specific Diseases
ANCA-Associated Vasculitis
DAH occurs in 25% of AAV patients and represents a life-threatening manifestation 6. Independent predictors of mortality include:
- Older age
- Severe kidney failure
- Degree of hypoxemia
- Involvement of >50% of lung area at presentation 6
Systemic Lupus Erythematosus
DAH is rare but carries exceptionally high mortality in SLE patients. Clinical recognition is particularly challenging as hemoptysis may be absent and early features overlap with infection or ARDS 3.
Prognosis
In-hospital mortality exceeds 20%, making DAH a true medical emergency requiring immediate recognition and intervention 1. The high mortality underscores the critical importance of early diagnosis and aggressive treatment.